Skip to site alert.
Skip to content
Showing 1 - 10 of 1967 results.
Columbia Psychiatry's Caroline Arout uses quantitative sensory testing, or QST, for assessing the effectiveness of cannabis for therapeutic uses.
Dr. Sidney Hankerson is one of 10 scholars named as 2021’s Emerging Leaders in Health and Medicine by the National Academy of Medicine (NAM).
Ravi N. Shah, MD has been named Chief Innovation Officer for Columbia Psychiatry.
A collaborative study from Columbia University and the Copenhagen Research Centre for Mental Health examines the relationship between Lyme disease and psychiatric outcomes.
Columbia Psychiatry News spoke with Dr. Scott Small about the science of memory and how we can get better at letting stuff go.
A Columbia University article in JAMA Psychiatry makes the case for doing more to make mental health care non-racist and to take steps for racial equity in clinics and communities.
Dr. Joshua Berman said electrical stimulation (ECT) seems to trigger the release of "neurotrophic" factors, which can help brain cells grow.
“Our study provides further evidence that marijuana use is not effective in reducing nonmedical opioid use,” said study author Dr. Mark Olfson.
“The biggest limiting factor in getting to remission from depression postpartum is access to care, period—and it is worse for people who don’t have financial resources,” says Dr. Catherine Monk.
Marijuana, Dr. Margaret Haney, said, “reduces reaction time and has other effects that would worsen performance.”